Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens

Immunological Reviews

Volumn 165, Issue , 1998, Pages 267-277

  Miller, J F A P ^a   Kurts, C ^a   Allison, J ^a   Kosaka, H ^b   Carbone, F ^a   Heath, W R ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; AUTOIMMUNITY; CELL DEATH; IMMUNOLOGICAL TOLERANCE; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

EID: 0031726905     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01244.x     Document Type: Review

References (69)

1. Von Boehmer H. Developmental biology of T cells in T cell-receptor transgenic mice. Annu Rev Immunol 1990;8:531-556.
2. Yan T, et al. Specificity and T cell receptor β chain usage of a human collagen type II-reactive T cell done derived from a healthy individual. Eur J Immunol 1992;22:51-56.
3. Burns J, Rosenzweig A, Zweiman B, Lisak RP. Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell Immunol 1983;81:435-440.
4. Wekerle H, Bradl M, Linington C, Kaab G, Kojima K. The shaping of the brain-specific T lymphocyte repertoire in the thymus. Immunol Rev 1996;149:231-243.
5. Ohashi PS, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991;65:305-317.
6. Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991;65:319-331.
7. Miller JFAP, Heath WR. Self-ignorance in the peripheral T-cell pool. Immunol Rev 1993;133:131-150.
8. Jolicoeur C, Hanahan D, Smith KM. T-cell tolerance toward a transgenic β-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc Natl Acad Sci USA 1994;91:6707-6711.
9. Mackay CR. Homing of naive, memory and effector lymphocytes. Curr Opin Immunol 1993;5:423-427.
10. Heath WR, et al. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 1992;359:547-549.
11. Bevan MJ. Antigen recognition. Class discrimination in the world of immunology. Nature 1987;325:192-194.
12. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994;76:287-299.
13. Allison JP. CD28-B7 interactions in T-cell activation. Curr Opin Immunol 1994;6:414-419.
14. Rock KL. A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today 1996;17:131-137.
15. Reis e Sousa C, Germain RN. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med 1995;182:841-851.
16. Bevan MJ. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 1976;143:1283-1288.
17. Gordon RD, Mathieson BJ, Samelson LE, Boyse EA, Simpson E. The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-Y antigen. J Exp Med 1976;144:810-820.
18. Gooding LR, Edwards CB. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J Immunol 1980;124:1258-1262.
19. Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994;264:961-965.
20. Yewdell JW, Bennink JR, Hosaka Y. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 1988;239:637-640.
21. Kurts C, Heath WR, Carbone FR, Allison J, Miller JFAP, Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996;184:923-930.
22. Fulcher DA, et al. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med 1996;183:2313-2328.
23. Miller JFAP, et al. T-cell tolerance and autoimmunity. Ciba Found Symp 1997;204:159-168.
24. Joplin R, et al. Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study. Hepatology 1991;14:442-447.
25. Voorby HA, et al. Dendritic cells and class II MHC expression on thyrocytes during the autoimmune thyroid disease of the BB rat. Clin Immunol Immunopathol 1990;55:9-22.
26. Mittrucker HW, Pfeffer K, Schmits R, Mat TW. T-lymphocyte development and function in gene-targeted mutant mice. Immunol Rev 1995;148:115-150.
27. Heath WR, Kurts C, Miller JFAP, Carbone FR. Cross-tolerance: a pathway for inducing tolerance to peripheral antigens. J Exp Med 1998;187:1549-1553.
28. Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970;169:1042-1049.
29. Kurts C, Miller JFAP, Subramanium R, Carbone FR, Heath WR. MHC class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med 1998;188:409-414.
30. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-89.
31. Allison J, Campbell IL, Morahan G, Mandel TE, Harrison LC, Miller JFAP. Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic β cells. Nature 1988;333:529-533.
32. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
33. + T cells. J Exp Med 1997;186:239-245.
34. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 1997;186:2057-2062.
35. Von Boehmer H, Hafen K. Minor but not major histocompatibility antigens of thymus epithelium tolerize precursors of cytolytic T cells. Nature 1986;320:626-628.
36. + T cells. Eur J Immunol 1992;22:1013-1022.
37. Guerder S, Matzinger P. A fail-safe mechanism for maintaining self-tolerance. J Exp Med 1992;176:553-564.
38. + cells after a transient response to antigen. Eur J Immunol 1993;23:1963-1967.
39. Buller RM, Holmes KL, Hugin A, Frederickson TN, Morse HC. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 1987;328:77-79.
40. Ahmed R, Butler LD, Bhatti L. T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J Virol 1988;62:2102-2106.
41. Von Herrath MG, Yokoyama M, Dockter J, Oldstone MB, Whitton JL. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol 1996;70:1072-1079.
42. + T cells. J Exp Med 1996;184:863-871.
43. Keene JA, Forman J. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med 1982;155:768-782.
44. Bennett SR, Carbone FR, Karamalis F, Miller JFAP, Heath WR. Induction of a CD8 cytotoxic T lymphocyte response by cross-priming requires cognate CD4 help. J Exp Med 1997;186:65-70.
45. Bennett SMR, Carbone FR, Karamalis F, Miller JFAP, Heath WR. Help for inducing cytotoxic T cell responses by cross-priming is mediated via CD40 signalling. Nature 1998;393:478-480.
46. Schoenberger SP, Toes REM, van der Voort EIH, Offringa R, Melief CJM. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998;393:480-483.
47. + T-helper and a T-killer cell. Nature 1998;393:474-478.
48. Fisher KJ, et al. Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 1997;3:306-312.
49. Grewal IS, et al. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 1996;273:1864-1867.
50. Shu U, et al. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995;25:1125-1128.
51. Di Rosa F, Matzinger P. Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells. J Exp Med 1996;183:2153-2163.
52. + T cell tolerance to parenchymil self antigens requires presentation by bone marrow derived antigen presenting cells. J Exp Med 1998;187:1555-1564.
53. Singer GG, Abbas AK. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-371.
54. Sytwu HK, Liblau RS, McDevitt HO. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996;5:17-30.
55. Van Parijs L, Peterson DA, Abbas AK. The fas/fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 1998;8:265-274.
56. + T cells specific for a pancreatic β cell neo-antigen. Immunity 1995;2:573-585.
57. Scott B, et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1994;1:73-82.
58. Russell JH, Rush B, Weaver C, Wang R. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 1993;90:4409-4413.
59. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995;373:438-441.
60. Ju ST, et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995;373:444-448.
61. Brunner T, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995;373:441-444.
62. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996;87:319-329.
63. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995;377:348-351.
64. Kurts C, Heath WR, Kosaka H, Miller JFAP, Carbone FR. The peripheral deletion of autoreactive CD8 T cells induced by cross-presentation of self antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med 1998;188:415-420.
65. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997;388:782-787.
66. Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995;182:459-465.
67. Vella AT, McCormack JE, Linsley PS, Kappler JW, Marrack P. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 1995;2:261-270.
68. Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995;269:1585-1588.
69. Ploegh HL. Viral strategies of immune evasion. Science 1998;280:248-253.